A selective novel low-molecular-weight inhibitor of I Κ B kinase- Β (IKK- Β ) prevents pulmonary inflammation and shows broad anti-inflammatory activity
dc.contributor.author | Ziegelbauer, Karl | en_US |
dc.contributor.author | Gantner, Florian | en_US |
dc.contributor.author | Lukacs, Nicholas W. | en_US |
dc.contributor.author | Berlin, Aaron | en_US |
dc.contributor.author | Fuchikami, Kinji | en_US |
dc.contributor.author | Niki, Toshiro | en_US |
dc.contributor.author | Sakai, Katsuya | en_US |
dc.contributor.author | Inbe, Hisayo | en_US |
dc.contributor.author | Takeshita, Keisuke | en_US |
dc.contributor.author | Ishimori, Mina | en_US |
dc.contributor.author | Komura, Hiroshi | en_US |
dc.contributor.author | Murata, Toshiki | en_US |
dc.contributor.author | Lowinger, Timothy | en_US |
dc.contributor.author | Bacon, Kevin B. | en_US |
dc.date.accessioned | 2010-06-01T19:36:52Z | |
dc.date.available | 2010-06-01T19:36:52Z | |
dc.date.issued | 2005-05 | en_US |
dc.identifier.citation | Ziegelbauer, Karl; Gantner, Florian; Lukacs, Nicholas W; Berlin, Aaron; Fuchikami, Kinji; Niki, Toshiro; Sakai, Katsuya; Inbe, Hisayo; Takeshita, Keisuke; Ishimori, Mina; Komura, Hiroshi; Murata, Toshiki; Lowinger, Timothy; Bacon, Kevin B (2005). "A selective novel low-molecular-weight inhibitor of I Κ B kinase- Β (IKK- Β ) prevents pulmonary inflammation and shows broad anti-inflammatory activity." British Journal of Pharmacology 145(2): 178-192. <http://hdl.handle.net/2027.42/72750> | en_US |
dc.identifier.issn | 0007-1188 | en_US |
dc.identifier.issn | 1476-5381 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/72750 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=15753951&dopt=citation | en_US |
dc.format.extent | 341841 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/octet-stream | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 2005 British Pharmacological Society | en_US |
dc.subject.other | Protein Kinases | en_US |
dc.subject.other | Asthma | en_US |
dc.subject.other | Inflammation | en_US |
dc.subject.other | Lung | en_US |
dc.subject.other | Signal Transduction | en_US |
dc.subject.other | Transcription Factors | en_US |
dc.title | A selective novel low-molecular-weight inhibitor of I Κ B kinase- Β (IKK- Β ) prevents pulmonary inflammation and shows broad anti-inflammatory activity | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | University of Michigan Medical School, Department of Pathology, Ann Arbor, MI, U.S.A. | en_US |
dc.identifier.pmid | 15753951 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/72750/1/sj.bjp.0706176.pdf | |
dc.identifier.doi | 10.1038/sj.bjp.0706176 | en_US |
dc.identifier.source | British Journal of Pharmacology | en_US |
dc.identifier.citedreference | ADCOCK, I. M. & ITO, K. ( 2004 ). Steroid resistance in asthma: a major problem requiring novel solutions or a non-issue. Curr. Opin. Pharmacol., 4, 257 – 262. | en_US |
dc.identifier.citedreference | BAEUERLE, P. A. & BAICHWAL, V. R. ( 1997 ). NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv. Immunol., 65, 111 – 137. | en_US |
dc.identifier.citedreference | BARNES, P. J. & ADCOCK, I. M. ( 1997 ). NF-kappa B: a pivotal role in asthma and a new target for therapy. Trends Pharmacol. Sci., 18, 46 – 50. | en_US |
dc.identifier.citedreference | BAXTER, A., BROUGH, S., COOPER, A., FLOETTMANN, E., FOSTER, S., HARDING, C., KETTLE, J., MCINALLY, T., MARTIN, C., MOBBS, M., NEEDHAM, M., NEWHAM, P., PAINE, S., ST-GALLAY, S., SALTER, S., UNITT, J. & XUE, Y. ( 2004 ). Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors. Bioorg. Med. Chem. Lett., 14, 2817 – 2822. | en_US |
dc.identifier.citedreference | BEASLEY, R. ( 2002 ). The burden of asthma with specific reference to the United States. J. Allergy Clin. Immunol., 109 ( Suppl ), S482 – S489. | en_US |
dc.identifier.citedreference | BELVISI, M. G., WICKS, S. L., BATTRAM, C. H., BOTTOMS, S. E., REDFORD, J. E., WOODMAN, P., BROWN, T. J., WEBBER, S. E. & FOSTER, M. L. ( 2001 ). Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity. J. Immunol., 166, 1975 – 1982. | en_US |
dc.identifier.citedreference | BOOTHBY, M., MORA, A. L., ARONICA, M. A., YOUN, J., SHELLER, J. R., GOENKA, S. & STEPHENSON, L. ( 2001 ). IL-4 signaling, gene transcription regulation, and the control of effector T cells. Immunol. Res., 23, 179 – 191. | en_US |
dc.identifier.citedreference | BURKE, J. R., PATTOLI, M. A., GREGOR, K. R., BRASSIL, P. J., MACMASTER, J. F., MCINTYRE, K. W., YANG, X., IOTZOVA, V. S., CLARKE, W., STRNAD, J., QIU, Y. & ZUSI, F. C. ( 2003 ). BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice. J. Biol. Chem., 278, 1256 – 1450. | en_US |
dc.identifier.citedreference | CAMANDOLA, S., LEONARDUZZI, G., MUSSO, T., VARESIO, L., CARINI, R., SCAVAZZA, A., CHIARPOTTO, E., BAEUERLE, P. A. & POLI, G. ( 1996 ). Nuclear factor Κ B is activated by arachidonic acid but not by eicosapentaenoic acid. Biochem. Biophys. Res. Commun., 229, 643 – 647. | en_US |
dc.identifier.citedreference | CAMPBELL, E. M., CHARO, I. F., KUNKEL, S. L., STRIETER, R. M., BORING, L., GOSLING, J. & LUKACS, N. W. ( 1999 ). Monocyte chemoattractant protein-1 mediates cockroach allergen-induced bronchial hyperreactivity in normal but not CCR2−/− mice: the role of mast cells. J. Immunol., 163, 2160 – 2167. | en_US |
dc.identifier.citedreference | CAMPBELL, E. M., KUNKEL, S. L., STRIETER, R. M. & LUKACS, N. W. ( 1998 ). Temporal role of chemokines in a murine model of cockroach allergen-induced airway hyperreactivity and eosinophilia. J. Immunol., 161, 7047 – 7053. | en_US |
dc.identifier.citedreference | CASTRO, A. C., DANG, L. C., SOUCY, F., GRENIER, L., MAZDIYASNI, H., HOTTELET, M., PARENT, L., PIEN, C., PALOMBELLA, V. & ADAMS, J. ( 2003 ). Novel IKK inhibitors: beta-carbolines. Bioorg. Med. Chem. Lett., 13, 2419 – 2422. | en_US |
dc.identifier.citedreference | CHEN, L. W., EGAN, L., LI, Z. W., GRETEN, F. R., KAGNOFF, M. F. & KARIN, M. ( 2003 ). The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia–reperfusion. Nat. Med., 9, 575 – 581. | en_US |
dc.identifier.citedreference | CHRISTMAN, J. W., SADIKOT, R. T. & BLACKWELL, T. S. ( 2000 ). The role of nuclear factor-kappa B in pulmonary diseases. Chest, 117, 1482 – 1487. | en_US |
dc.identifier.citedreference | D'ACQUISTO, F., IANARO, A., IALENTI, A., IUVONE, T., COLANTUONI, V. & CARNUCCIO, R. ( 1999 ). Activation of nuclear transcription factor kappaB in rat carrageenin-induced pleurisy. Eur. J. Pharmacol., 369, 233 – 236. | en_US |
dc.identifier.citedreference | DAS, J., CHEN, C. H., YANG, L., COHN, L., RAY, P. & RAY, A. ( 2001 ). A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat. Immunol., 2, 45 – 50. | en_US |
dc.identifier.citedreference | DE BOSSCHER, K., VAN DEN BERGHE, W. & HAEGEMAN, G. ( 2003 ). The interplay between the glucocorticoid receptor and nuclear factor-kappa B or activator protein-1: molecular mechanisms for gene repression. Endocr. Rev., 24, 488 – 522. | en_US |
dc.identifier.citedreference | DONOVAN, C. E., MARK, D. A., HE, H. Z., LIOU, H. C., KOBZIK, L., WANG, Y, DE SANCTIS, G. T., PERKINS, D. L. & FINN, P. W. ( 1999 ). NF-kappa B/Rel transcription factors: c-Rel promotes airway hyperresponsiveness and allergic pulmonary inflammation. J. Immunol., 163, 6827 – 6833. | en_US |
dc.identifier.citedreference | ELLIOTT, P. J., PIEN, C. S., MCCORMACK, T. A., CHAPMAN, I. D. & ADAMS, J. ( 1999 ). Proteasome inhibition: a novel mechanism to combat asthma. J. Allergy Clin. Immunol., 104, 294 – 300. | en_US |
dc.identifier.citedreference | GAGLIARDO, R., CHANEZ, P., MATHIEU, M., BRUNO, A., COSTANZO, G., GOUGAT, C., VACHIER, I., BOUSQUET, J., BONSIGNORE, G. & VIGNOLA, A. M. ( 2003 ). Persistent activation of nuclear factor-kappaB signaling pathway in severe uncontrolled asthma. Am. J. Respir. Crit. Care Med., 168, 1190 – 1198. | en_US |
dc.identifier.citedreference | GLEICH, G. J. ( 2000 ). Mechanisms of eosinophil-associated inflammation. J. Allergy Clin. Immunol., 105, 651 – 663. | en_US |
dc.identifier.citedreference | GOSH, S. & KARIN, M. ( 2002 ). Missing pieces in the NF- Κ B puzzle. Cell, 109, S81 – S86. | en_US |
dc.identifier.citedreference | HART, L. A., KRISHNAN, V. L., ADCOCK, I. M., BARNES, P. J. & CHUNG, K. F. ( 1998 ). Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. Am. J. Respir. Crit. Care Med., 158, 1585 – 1592. | en_US |
dc.identifier.citedreference | HECKMANN, A., WALTZINGER, C., JOLICOEUR, P., DREANO, M., KOSCO-VILBOIS, M. H. & SAGOT, Y. ( 2004 ). IKK2 inhibitor alleviates kidney and wasting diseases in a murine model of human AIDS. Am. J. Pathol., 164, 1253 – 1262. | en_US |
dc.identifier.citedreference | HIDESHIMA, T., CHAUHAN, D., RICHARDSON, P., MITSIADES, C., MITSIADES, N., HAYASHI, T., MUNSHI, N., DANG, L., CASTRO, A., PALOMBELLA, V., ADAMS, J. & ANDERSON, K. C. ( 2002 ). NF-kappa B as a therapeutic target in multiple myeloma. J. Biol. Chem., 277, 16639 – 16647. | en_US |
dc.identifier.citedreference | HU, Y. L., BAUD, V., DELHASE, M., ZHANG, P., DEERINCK, T., ELLISMAN, M., JOHNSON, R. & KARIN, M. ( 1999 ). Abnormal morphogenesis but intact IKK activation in mice lacking the IKK alpha subunit of I kappa B kinase. Science, 284, 316 – 320. | en_US |
dc.identifier.citedreference | HU, Y. L., BAUD, V., OGA, T., KIM, K. I., YOSHIDA, K. & KARIN, M. ( 2001 ). IKK alpha controls formation of the epidermis independently of NF-kappa B. Nature, 410, 710 – 714. | en_US |
dc.identifier.citedreference | INOUE, H. & TANABE, T. ( 1998 ). Transcriptional role of the nuclear factor kappa B site in the induction by lipopolysaccharide and suppression by dexamethasone of cyclooxygenase-2 in U937 cells. Biochem. Biophys. Res. Commun., 244, 143 – 148. | en_US |
dc.identifier.citedreference | KARIN, M., YAMAMOTO, Y. & WANG, Q. M. ( 2004 ). The IKK NF-kappa B system: a treasure trove for drug development. Nat. Rev. Drug Discov., 3, 17 – 26. | en_US |
dc.identifier.citedreference | KISHORE, N., SOMMERS, C., MATHIALAGAN, S., GUZOVA, J., YAO, M., HAUSER, S., HUYNH, K., BONAR, S., MIELKE, C., ALBEE, L., WEIER, R., GRANETO, M., HANAU, C., PERRY, T. & TRIPP, C. S. ( 2003 ). A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts. J. Biol. Chem., 278, 32861 – 32871. | en_US |
dc.identifier.citedreference | LEUNG, D. Y. & BLOOM, J. W. ( 2003 ). Update on glucocorticoid action and resistance. J. Allergy Clin. Immunol., 111, 3 – 22. | en_US |
dc.identifier.citedreference | LI, J., PEET, G. W., PULLEN, S. S., SCHEMBRI-KING, J., WARREN, T. C., MARCU, K. B., KEHRY, M. R., BARTON, R. & JAKES, S. ( 1998 ). Recombinant I kappa B kinases alpha and beta are direct kinases of I kappa B alpha. J. Biol. Chem., 273, 30736 – 30741. | en_US |
dc.identifier.citedreference | LI, Q. T., VAN ANTWERP, D., MERCURIO, F., LEE, K. F. & VERMA, I. M. ( 1999 ). Severe liver degeneration in mice lacking the I kappa B kinase 2 gene. Science, 284, 321 – 325. | en_US |
dc.identifier.citedreference | LI, X., MASSA, P. E., HANIDU, A., PEET, G. W., ARO, P., SAVITT, A., MISCHE, S., LI, J. & MARCU, K. B. ( 2002 ). IKK alpha, IKK beta, and NEMO/IKK gamma are each required for the NF-kappa B-mediated inflammatory response program. J. Biol. Chem., 277, 45129 – 45140. | en_US |
dc.identifier.citedreference | LI, Z. W., CHU, W., HU, Y., DELHASE, M., DEERINCK, T., ELLISMAN, M., JOHNSON, R. & KARIN, M. ( 1999 ). The IKK beta subunit of I kappa B kinase (IKK) is essential for nuclear factor kappa B activation and prevention of apoptosis. J. Exp. Med., 189, 1839 – 1845. | en_US |
dc.identifier.citedreference | LI, Z. W., OMORI, S. A., LABUDA, T., KARIN, M. & RICKERT, R. C. ( 2003 ). IKK beta is required for peripheral B cell survival and proliferation. J. Immunol., 170, 4630 – 4637. | en_US |
dc.identifier.citedreference | MACMASTER, J. F., DAMBACH, D. M., LEE, D. B., BERRY, K. K., QIU, Y., ZUSI, F. C. & BURKE, J. R. ( 2003 ). An inhibitor of IkappaB kinase, BMS-345541, blocks endothelial cell adhesion molecule expression and reduces the severity of dextran sulfate sodium-induced colitis in mice. Inflamm. Res., 52, 508 – 511. | en_US |
dc.identifier.citedreference | MCINTYRE, K. W., SHUSTER, D. J., GILLOOLY, K. M., DAMBACH, D. M., PATTOLI, M. A., LU, P., ZHOU, X. D., QIU, Y., ZUSI, F. C. & BURKE, J. R. ( 2003 ). A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice. Arthritis Rheum., 48, 2652 – 2659. | en_US |
dc.identifier.citedreference | MULLER, J. R. & SIEBENLIST, U. ( 2003 ). Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways. J. Biol. Chem., 278, 12006 – 12012. | en_US |
dc.identifier.citedreference | MURATA, T., SHIMADA, M., KADONO, H., SAKAKIBARA, S., YOSHINO, T., MASUDA, T., SHIMAZAKI, M., SHINTANI, T., FUCHIKAMI, K., BACON, K. B., ZIEGELBAUER, K. B. & LOWINGER, T. B. ( 2004a ). Synthesis and structure–activity relationships of novel IKK-beta inhibitors. Part 2: improvement of in vitro activity. Bioorg. Med. Chem. Lett., 14, 4013 – 4017. | en_US |
dc.identifier.citedreference | MURATA, T., SHIMADA, M., SAKAKIBARA, S., YOSHINO, T., KADONO, H., MASUDA, T., SHIMAZAKI, M., SHINTANI, T., FUCHIKAMI, K., SAKAI, K., INBE, H., TAKESHITA, K., NIKI, T., UMEDA, M., BACON, K. B., ZIEGELBAUER, K. B. & LOWINGER, T. B. ( 2003 ). Discovery of novel and selective IKK-serine–threonine protein kinase inhibitors. Bioorg. Med. Chem. Lett., 13, 913 – 918. | en_US |
dc.identifier.citedreference | MURATA, T., SHIMADA, M., SAKAKIBARA, S., YOSHINO, T., MASUDA, T., SHINTANI, T., SATO, H., KORIYAMA, Y., FUKUSHIMA, K., NUNAMI, N., YAMAUCHI, M., FUCHIKAMI, K., KOMURA, H., WATANABE, A., ZIEGELBAUER, K. B., BACON, K. B. & LOWINGER, T. B ( 2004b ). Synthesis and structure–activity relationships of novel IKK-beta inhibitors. Part 3: Orally active anti-inflammatory agents. Bioorg. Med. Chem. Lett., 14, 4019 – 4022. | en_US |
dc.identifier.citedreference | NEWTON, R., KUITERT, L. M., BERGMANN, M., ADCOCK, I. M. & BARNES, P. J. ( 1997 ). Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. Biochem. Biophys. Res. Commun., 237, 28 – 32. | en_US |
dc.identifier.citedreference | PASPARAKIS, M., SCHMIDT-SUPPRIAN, M. & RAJEWSKY, K. ( 2002 ). IkappaB kinase signaling is essential for maintenance of mature B cells. J. Exp. Med., 196, 743 – 752. | en_US |
dc.identifier.citedreference | POYNTER, M. E., IRVIN, C. G. & JANSSEN-HEININGER, Y. M. ( 2002 ). Rapid activation of nuclear factor-kappaB in airway epithelium in a murine model of allergic airway inflammation. Am. J. Pathol., 160, 1325 – 1334. | en_US |
dc.identifier.citedreference | PUIGNERO, V. & QUERALT, J. ( 1997 ). Effect of topically applied cyclooxygenase-2-selective inhibitors on arachidonic acid- and tetradecanoylphorbol acetate-induced dermal inflammation in the mouse. Inflammation, 21, 431 – 442. | en_US |
dc.identifier.citedreference | ROTHWARF, D. M. & KARIN, M. ( 1999 ). The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus. Sci STKE, 5, RE1. | en_US |
dc.identifier.citedreference | RUDOLPH, D., YEH, W. C., WAKEHAM, A., RUDOLPH, B., NALLAINATHAN, D., POTTER, J., ELIA, A. J. & MAK, T. W. ( 2000 ). Severe liver degeneration and lack of NF-kappa B activation in NEMO/IKK gamma-deficient mice. Genes Dev., 14, 854 – 862. | en_US |
dc.identifier.citedreference | SALLUSTO, F. & LANZAVECCHIA, A. ( 1994 ). Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med., 17, 1109 – 1118. | en_US |
dc.identifier.citedreference | SENFTLEBEN, U., CAO, Y., XIAO, G., GRETEN, F. R., KRAHN, G., BONIZZI, G., CHEN, Y., HU, Y., FONG, A., SUN, S. C. & KARIN, M. ( 2001 ). Activation by IKK alpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science, 293, 1495 – 1499. | en_US |
dc.identifier.citedreference | SIL, A. K., MAEDA, S., SANO, Y., ROOP, D. R. & KARIN, M. ( 2004 ). IkB kinase-alpha acts in the epidermis to control skeletal and craniofacial morphogenesis. Nature, 442, 660 – 664. | en_US |
dc.identifier.citedreference | STACEY, M. A., SUN, G., VASSALLI, G., MARINI, M., BELLINI, A. & MATTOLI, S ( 1997 ). The allergen Der p1 induces NF-kappaB activation through interference with IkappaB alpha function in asthmatic bronchial epithelial cells. Biochem. Biophys. Res. Commun., 236, 522 – 526. | en_US |
dc.identifier.citedreference | TAKEDA, K., TAKEUCHI, O., TSUJIMURA, T., ITAMI, S., ADACHI, O., KAWAI, T., SANJO, H., YOSHIKAWA, K., TERADA, N. & AKIRA, S. ( 1999 ). Limb and skin abnormalities in mice lacking IKKalpha. Science, 284, 313 – 316. | en_US |
dc.identifier.citedreference | TANAKA, M., FUENTES, M. E., YAMAGUCH, I. K., DURNIN, M. H., DALRYMPLE, S. A., HARDY, K. L. & GOEDDEL, D. V. ( 1999 ). Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. Immunity, 10, 421 – 429. | en_US |
dc.identifier.citedreference | TEGEDER, I., NIEDERBERGER, E., SCHMIDT, R., KUNZ, S., GUHRING, H., RITZELER, O., MICHAELIS, M. & GEISSLINGER, G ( 2004 ). Specific inhibition of IkappaB kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats. J. Neurosci., 24, 1637 – 1645. | en_US |
dc.identifier.citedreference | TOWNSEND, R. M., POSTELNEK, J., SUSULIC, V., MCINTYRE, K. W., SHUSTER, D. J., QIU, Y., ZUSI, F. C. & BURKE, J. R. ( 2004 ). A highly selective inhibitor of IkappaB kinase, BMS-345541, augments graft survival mediated by suboptimal immunosuppression in a murine model of cardiac graft rejection. Transplantation, 77, 1090 – 1094. | en_US |
dc.identifier.citedreference | VERMA, I. M., STEVENSON, J. K., SCHWARZ, E. M., VAN ANTWERP, D. & MIYAMOTO, S. ( 1995 ). Rel/Nf-Kappa B/I Kappa B family: intimate tales of association and dissociation. Genes Dev., 9, 2723 – 2735. | en_US |
dc.identifier.citedreference | WENZEL, S. ( 2003 ). Mechanisms of severe asthma. Clin. Exp. Allergy, 33, 1622 – 1628. | en_US |
dc.identifier.citedreference | YAMAMOTO, Y. & GAYNOR, R. B. ( 2004 ). IkappaB kinases: key regulators of the NF-kappaB pathway. Trends Biochem. Sci., 29, 72 – 79. | en_US |
dc.identifier.citedreference | YANG, L., COHN, L., ZHANG, D. H., HOMER, R., RAY, A. & RAY, P. ( 1998 ). Essential role of nuclear factor kappa B in the induction of eosinophilia in allergic airway inflammation. J. Exp. Med., 188, 1739 – 1750. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.